Safety of Radiofrequency Catheter Ablation in Patients with Supraventricular Tachycardia Confirmed by Means of Echocardiography

1995 ◽  
Vol 3 (1) ◽  
pp. 27
Author(s):  
Yoon-Nyun Kim ◽  
Kee-Sik Kim ◽  
Sung-Ho Hur
1999 ◽  
Vol 9 (4) ◽  
pp. 377-383 ◽  
Author(s):  
Ruchir Sehra ◽  
Joyce E. Hubbard ◽  
Susan P. Straka ◽  
Naomi S. Fineberg ◽  
Douglas P. Zipes ◽  
...  

AbstractBackgroundRadiofrequency catheter ablation is standard treatment for children with re-entrant supraventricular tachycardias. Autonomic changes have been noted after such ablation for atrioventricular nodal re-entry tachycardia, but not as well documented with atrioventricular re-entry over an accessory pathway.Methods and resultsIn 10 normal paediatric volunteers and 12 children referred for electrophysiologic testing and radiofrequency ablation of supraventricular tachycardia, non-invasive autonomic function tests and tilt-table testing were performed, and the variability in 24-h heart rate was analysed. Patients with supraventricular tachycardia underwent these tests both 24–72 h before and 24 h after ablation. Patients with tachycardia underwent additional autonomic testing to assess the sensitivity of baroreceptors and the intrinsic heart rate with autonomic blockade immediately before and after ablation. One non-invasive autonomic function test, namely handgrip, demonstrated significant differences (p < 0.05) in diastolic blood pressure before and after ablation, though these values did not differ from controls. Significant decreases were noted in two indexes of the variability of heart rate before and after ablation (p < 0.05). Certain tilt test variables also demonstrated significant differences between controls and those with tachycardia subsequent to ablation. Intracardiac testing demonstrated changes (p < 0.05) in sinus cycle lengths, effective refractory periods and/or blood pressures at baseline and during testing of the sensitivity of baroreceptors before and after ablation. These changes were consistent with increased sympathetic or decreased parasympathetic tone. With autonomic blockade, these differences were abolished.ConclusionsCatheter ablation of accessory pathways in children was associated with changes consistent with increased sympathetic or decreased parasympathetic tone. These autonomic changes persisted 24 h after the ablation procedure.


1992 ◽  
Vol 20 (6) ◽  
pp. 1405-1410 ◽  
Author(s):  
Christopher L. Case ◽  
Paul C. Gillette ◽  
Paul C. Oslizlok ◽  
Barbara J. Knick ◽  
Henry L. Blair

1992 ◽  
Vol 327 (5) ◽  
pp. 313-318 ◽  
Author(s):  
Warren M. Jackman ◽  
Karen J. Beckman ◽  
James H. McClelland ◽  
Xunzhang Wang ◽  
Karen J. Friday ◽  
...  

2008 ◽  
Vol 5 (1) ◽  
pp. 19-21
Author(s):  
Man Bahadur KC ◽  
Sujeeb Rajbhandari ◽  
Roshan Raut

Shahid Gangalal National Heart Center (SGNHC) is the first and the only one facility providing electrophysiological studies (EPS) and radiofrequency catheter ablation (RFCA) for supraventricular tachycardia in Nepal. The first RFCA for SVT in Nepal was performed on 13th October 2003 with Portable EP lab (EP Tracer-Johnson & Johnson). To date, total of 248 RFCA procedures have been performed in SGNHC. The retrospective analysis of this patients population has provided an opportunity to narrate our initial experience regarding baseline characteristics, EP findings, immediate and follow up outcomes and complications.


Author(s):  
Chien-Lung Chan ◽  
Ai-Hsien Adams Li ◽  
Hsiang-An Chung ◽  
Dinh-Van Phan

Recurrence of paroxysmal supraventricular tachycardia (PSVT) has been reported to be lower in patients treated with radiofrequency catheter ablation (RFCA) than in those who are not. Few population-based surveys have stated the cost-effectiveness related to this treatment. We, therefore, performed a nationwide retrospective study using National Health Insurance Research Database (NHIRD) data from 2001–2012 in Taiwan. The incidence of PSVT-related admissions was computed from patients’ first admission for a primary PSVT diagnosis. There were 21,086 patients hospitalized due to first-time PSVT, of whom 13,075 underwent RFCA, with 374 recurrences (2.86%). In contrast, 1751 (21.86%) of the remaining 8011 patients who did not receive RFCA, most of whom had financial concerns, experienced PSVT recurrence. The relative PSVT recurrence risk in those who did not receive RFCA was 7.6 times (95% CI: 6.67–8.33) that of those who did undergo RFCA. In conclusion, the PSVT recurrence rate was much higher in patients who did not receive RFCA at their first admission. Furthermore, RFCA proved cost-effective, with the ratio of the incremental cost-effectiveness ratio (ICER) and gross domestic product (GDP) being only 1.15. To prevent readmission and avoid incremental cost, the authority could provide a financial supplement for every patient so that the procedure is performed, reducing the PSVT-recurrence life-years (disease-specific DALY).


2013 ◽  
Vol 36 (12) ◽  
pp. 1488-1494 ◽  
Author(s):  
HYO SOON AN ◽  
EUN YOUNG CHOI ◽  
BO SANG KWON ◽  
GI BEOM KIM ◽  
EUN JUNG BAE ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document